2016 - TID Conference


Session 3 : Post-Transplant - Day 30 to Day 100

3.0 - How I Manage CMV Post-Transplant - Incorporating Immune Monitoring and Handling Antiviral Resistance

Presenter: Camille, Kotton, Boston, United States
Authors:

CMV is the most common infection after solid organ transplantation. Through optimal method of prevention, diagnosis and treatment of CMV, overall outcomes can be significantly enhanced. Guidelines have been developed that encourage best practices, which will be reviewed. In recent years, multiple new agents with activity against CMV have appeared on the horizon, and their role in management of transplant patients will be mentioned. In addition, novel diagnostics may help manage complex patients. Advances in the field, as well as novel concepts and expert opinions, will be covered in this talk.

 


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada